Scarica l'app Stockscreener
1.21
6.20%
-0.08
Pmv Pharmaceuticals Inc Azioni (PMVP) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Operating Expenses |
0.73%
18.88
|
19.02 | 19.24 | 22.52 | 22.88 |
| Operating Income/Loss |
0.73%
-18.88
|
-19.02 | -19.24 | -22.52 | -22.88 |
| Net Interest Income/Expense |
19.59%
0.788
|
0.98 | 1.232 | 1.48 | 1.69 |
| Income/Loss From Continuing Operations Before Tax |
0.25%
-18.08
|
-18.04 | -18.01 | -21.07 | -21.20 |
| Income Tax Expense/Benefit |
0.003
|
- | 0.026 | -0.006 | 0.005 |
| Net Income/Loss |
0.27%
-18.09
|
-18.04 | -18.04 | -21.06 | -21.21 |
| Basic Average Shares |
0.10%
53.39
|
53.33 | 0.2191 | 52.99 | 52.01 |
| Diluted Average Shares |
0.10%
53.39
|
53.33 | 0.2191 | 52.99 | 52.01 |
| Basic Earnings Per Share |
0.00%
-0.34
|
-0.34 | -0.34 | -0.40 | -0.41 |
| Diluted Earnings Per Share |
0.00%
-0.34
|
-0.34 | -0.34 | -0.40 | -0.41 |
4.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):